Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.41M Buy
5,718
+116
+2% +$27.8K 0.9% 21
2025
Q2
$1.35M Buy
5,602
+1,040
+23% +$242K 0.87% 26
2025
Q1
$1.03M Buy
4,562
+326
+8% +$71.7K 0.78% 26
2024
Q4
$871K Buy
+4,236
New +$929K 0.67% 27

Other funds holding STE

Promus Capital's STE Position: Q3 2025 in Review

Promus Capital increased its Steris (STE) stake by 2.1% in Q3 2025, buying an estimated $27.8K and bringing the position to 5,718 shares worth $1.41M. The position accounts for 0.9% of the portfolio, ranked #21.

Promus Capital first reported a position in STE in Q4 2024 and has held it in 4 quarters since. 842 funds tracked by Wall St. Rank hold STE as of Q3 2025.

  • Promus Capital held 5,718 shares of Steris worth $1.41M as of Q3 2025.
  • Promus Capital bought 116 Steris shares in Q3 2025, an estimated $27.8K.
  • Steris made up 0.9% of Promus Capital's portfolio in Q3 2025, its #21 holding.
  • Promus Capital first reported a position in Steris in Q4 2024 and has held it in 4 quarters since.
  • 842 funds tracked by Wall St. Rank held Steris as of Q3 2025.

Based on Promus Capital's 13F filing for Q3 2025, filed 13 Nov 2025.